24 May 2013
Keywords: bayer, stops, non-cabg, trasylol, studies, german, drugmaker
Article | 05 February 2007
German drugmaker Bayer says that it has stopped trials of its product Trasylol (aprotinin injection) in non-coronary artery bypass graft
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 February 2007
12 February 2007
23 May 2013
© 2013 thepharmaletter.com